Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery

Frontiers in Behavioral Neuroscience
Adam Michael StewartAllan V Kalueff

Abstract

The high prevalence of brain disorders and the lack of their efficient treatments necessitate improved in-vivo pre-clinical models and tests. The zebrafish (Danio rerio), a vertebrate species with high genetic and physiological homology to humans, is an excellent organism for innovative central nervous system (CNS) drug discovery and small molecule screening. Here, we outline new strategies for developing higher-throughput zebrafish screens to test neuroactive drugs and predict their pharmacological mechanisms. With the growing application of automated 3D phenotyping, machine learning algorithms, movement pattern- and behavior recognition, and multi-animal video-tracking, zebrafish screens are expected to markedly improve CNS drug discovery.

References

Oct 29, 1999·Genes & Development·A AmsterdamN Hopkins
Feb 13, 2001·Pharmacology, Biochemistry, and Behavior·R GerlaiA Rosenthal
May 6, 2008·The Journal of Experimental Biology·Layla J M KilyCaroline H Brennan
May 27, 2008·Nature Biotechnology·Yannick DoyonSharon L Amacher
Sep 12, 2008·Briefings in Functional Genomics & Proteomics·David Kokel, Randall T Peterson
Oct 3, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Athina MarkouThomas Steckler
Nov 26, 2008·Briefings in Functional Genomics & Proteomics·Cecilia B MoensTaylur P Ma
Jun 23, 2009·Behavioural Brain Research·Rupert J EganAllan V Kalueff
Oct 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Andrew M PetzoldStephen C Ekker
Jan 19, 2010·Nature Chemical Biology·David KokelRandall T Peterson
Feb 2, 2010·Behavioural Brain Research·Caio MaximinoAmauri Gouveia
Jun 16, 2010·Brain Research·Keith WongAllan V Kalueff
Jun 22, 2010·Behavioural Brain Research·Leah GrossmanAllan V Kalueff
Jul 27, 2010·Behavioural Brain Research·Yi PanRobert Gerlai
Oct 27, 2010·Behavioural Brain Research·Priya MathurSu Guo
Oct 30, 2010·Nature Protocols·Jonathan CachatAllan V Kalueff
Jan 18, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Caio MaximinoAnderson Manoel Herculano
Mar 5, 2011·Nature Protocols·Priya MathurSu Guo
Mar 17, 2011·PloS One·Jonathan CachatAllan V Kalueff
Sep 29, 2011·Methods in Cell Biology·David Kokel, Randall T Peterson
Oct 1, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William H J NortonLaure Bally-Cuif
Dec 20, 2011·Nature Chemical Biology·Christian LaggnerBrian K Shoichet
Jan 19, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Evan J KyzarAllan V Kalueff
Jan 24, 2012·Behavioural Brain Research·Ruxandra M Luca, Robert Gerlai
Aug 14, 2012·Journal of Neuroscience Methods·Jeremy GreenAllan V Kalueff
Sep 11, 2012·Journal of Biomolecular Screening·Shan JinRandall T Peterson
Oct 23, 2012·Frontiers in Behavioral Neuroscience·Brian B GriffithsEthan Gahtan
Jan 31, 2013·Nature Biotechnology·Woong Y HwangJ Keith Joung
Mar 15, 2013·Neurochemistry International·Adam Michael StewartAllan V Kalueff
Apr 18, 2013·Zebrafish·Allan V KalueffUNKNOWN Zebrafish Neuroscience Research Consortium
Jul 23, 2013·Zebrafish·Matthew O ParkerCaroline H Brennan
Jul 26, 2013·ACS Chemical Neuroscience·Nikhil NeelkantanAllan V Kalueff
Aug 31, 2013·Nature Reviews. Drug Discovery·Guy Griebel, Andrew Holmes
Oct 23, 2013·PloS One·Sachit ButailMaurizio Porfiri
Oct 24, 2013·Nature Reviews. Neuroscience·Adam Michael Stewart, Allan V Kalueff

❮ Previous
Next ❯

Citations

Sep 16, 2015·Aquatic Toxicology·Allan V KalueffUNKNOWN International Zebrafish Neuroscience Research Consortium ZNRC
Dec 19, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Nadia TabassumDarren R Williams
Apr 7, 2016·Neuroscience and Biobehavioral Reviews·Judith R HombergAllan V Kalueff
Apr 23, 2015·The European Journal of Neuroscience·Cameron WyattEmre Yaksi
Apr 7, 2015·Zebrafish·Violet MwaffoMaurizio Porfiri
Jun 24, 2016·Journal of Cardiovascular Development and Disease·Daniel R BrownJiandong Liu
Oct 31, 2016·Experimental Hematology·Adam P DeveauJason N Berman
Feb 22, 2017·British Journal of Pharmacology·Kanza M KhanDavid J Echevarria
Aug 11, 2017·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Yuhei Nishimura
Jul 4, 2020·The European Journal of Neuroscience·Murilo S de AbreuAllan V Kalueff
Aug 29, 2020·Journal of Psychopharmacology·Ana Cvv GiacominiMurilo S de Abreu
May 14, 2016·Physical Review. E·Sachit ButailMaurizio Porfiri
Feb 11, 2020·Stress : the International Journal on the Biology of Stress·Konstantin A DeminAllan V Kalueff
May 10, 2018·Neurochemical Research·Darya A MeshalkinaAllan V Kalueff
Aug 30, 2020·Disease Models & Mechanisms·Gideon L HughesMary Elizabeth Pownall
Feb 2, 2021·Toxicology and Applied Pharmacology·Mateusz PierógPiotr Wlaź
Mar 27, 2021·Frontiers in Cell and Developmental Biology·Dávid CzimerMáté Varga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Molecular Psychiatry
Adam Michael StewartAllan V Kalueff
Journal of Pharmacological and Toxicological Methods
F M RichardsT H Hutchinson
Progress in Neuro-psychopharmacology & Biological Psychiatry
Michael NguyenAllan V Kalueff
© 2022 Meta ULC. All rights reserved